Monday, 18 Mar 2019

You are here

Ten Contemporary Challenges Facing Lupus Treatment

A group of French researchers have pooled their interests to identify the challenges ahead in the management of patients with systemic lupus erythematosus (SLE). 

This introspective review puts forth the authors’ perceptions of the 10 most important contemporary challenges in the management of SLE. The paper represents the roundtable consensus of a multidisciplinary team of clinicians, pharmacists and researchers from a national centre for rare autoimmune and systemic diseases (Strasbourg, France).

The 10 main contemporary challenges in SLE include: 

  • T2T: favouring disease remission (or low disease activity).
  • Limiting the use of glucocorticoids.
  • Deriving more comprehensive tools for the evaluation of disease activity.
  • Developing more effective (and better tolerated) drugs (and more successful trials).
  • Dissecting the heterogeneity of the disease at the molecular and genetic levels.
  • Identifying relevant biomarkers for individualised treatment.
  • Managing fertility and pregnancy.
  • Managing comorbidities(e.g., cardiovascular risk, infections, osteoporosis).
  • Improving the network of care (the patients’ perspective).
  • Favouring a holistic approach (integrating fatigue, adherence to treatment, physical activity).

These 10 contemporary challenges in SLE may be considered as a roadmap for those involved in the daily care of patients with SLE, as well as for researchers who may wish to contribute to an improved management of this rare and complex disease.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Brazilian Guidelines for Systemic Autoimmune Myopathies

The Myopathy Committee of the Brazilian Society of Rheumatology (BSR) has put forward recommendations for the management of patients with systemic autoimmune myopathies (SAM).

The challenge has been that there is a paucity of effective controlled clinical trials, and hence, glucocorticoids (GC) have played a first-line and prominent role in the treatment of SAM.

EULAR Consensus Guidelines for Juvenile Localized Scleroderma

A EULAR international committee of 15 experts in pediatric rheumatology have established consensus-based recommendations for the management of juvenile localised scleroderma (JLS).

JLS is an uncommon disorder that is commonly seen by pediatric and adult rheumatologists. Evidence-based guidelines are sparse and management is mostly based on physicians’ experience.

2018 Swedish Guidelines for Giant Cell Arteritis Treatment

The Swedish Society of Rheumatology has developed evidence-based guidelines for the management of giant cell arteritis (GCA) with a focus on the appropriate use of corticosteroids and tocilizumab. 

Congenital Heart Block: Dangers Ahead

Children of autoantibody-positive mothers who were born with congenital heart block were at high risk for developing later cardiovascular and autoimmune disorders, as were their siblings, Swedish researchers reported.

Lower Mortality Results from Lower Activity in Lupus

Data from the longitudinal Tromsø Lupus Cohort study has shown that lupus patients who achieve a Lupus Low Disease Activity State (LLDAS‐50) were shown to have significantly less severe damage, and a reduction in mortality. This was a population‐based study of SLE patients in the northern‐most counties of Norway.